Medison, Alnylam Expand RNAi Partnership To More Regions
30 Apr 2024 //
PR NEWSWIRE
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals
08 Jan 2024 //
PR NEWSWIRE
Regeneron passes some European Libtayo rights to Medison Pharma
08 Jan 2024 //
FIERCE PHARMA
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay
13 Nov 2023 //
PR NEWSWIRE
Medison Announces Public Formulary Listing of QINLOCK in Canadian Provinces
29 Sep 2023 //
PR NEWSWIRE
Alnylam Pharmaceuticals & Medison Announce the Expansion of Their Collaboration
09 Mar 2023 //
PR NEWSWIRE
Medison Pharma Expands Partnership with Albireo to a Multi-Regional Agreement
16 Aug 2022 //
PRNEWSWIRE
Medison Pharma Announces Multi-Regional Partnership Agreement with argenx
06 Jun 2022 //
PRNEWSWIRE
Medison Pharma Extends Multi-territorial Agreement with Immunocore
23 May 2022 //
PRNEWSWIRE
BeiGene and Medison Announce Approval and National Reimbursement for BRUKINSA
15 Mar 2022 //
BUSINESSWIRE
Victor Papamoniodis Joins Medison Pharma as VP International Markets
20 Jan 2022 //
PRNEWSWIRE
Hansa & Medison partner for desensitization treatment for kidney transplant
07 Dec 2021 //
PRNEWSWIRE
Immunocore and Medison Pharma Partner for Future Commercialization
18 Oct 2021 //
GLOBENEWSWIRE
Moderna and Medison Pharma partner to commercialize Moderna`s COVID-19 vaccine
07 Jun 2021 //
PRNEWSWIRE
Rigel and Medison Announce Health Canada Approval of TAVALISSE®
23 Nov 2020 //
PRNEWSWIRE
Tris Pharma and Medison Pharma Announce Exclusive License Agreement
17 Nov 2020 //
BIOSPACE
Medison Pharma Enters Exclusive Distribution Agreement with Deciphera
06 Nov 2020 //
PRNEWSWIRE
Medison Pharma Enters Exclusive Distribution Agreement with Deciphera
06 Nov 2020 //
PRNEWSWIRE
Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology
15 Jun 2020 //
PRNEWSWIRE